Clinical Trial Update: Study of Safety and Effects of MDMA-assisted Therapy for Treatment of PTSD [Phase 2]

View source ↗

Summary

A Phase 2 study assessing MDMA-assisted therapy for Posttraumatic Stress Disorder has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Posttraumatic Stress Disorder

Drugs mentioned

• MDMA (3,4-methylenedioxymethamphetamine)

Snippet

Sponsor: Lykos Therapeutics | Conditions: Posttraumatic Stress Disorder | Phase 2 | Status: WITHDRAWN